# US 6,727,077 B1 · Heregulin-like factor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,077 B1
- Document ID: US6727077B1
- Status: Granted
- Kind: B1
- Application number: 09/097,681
- Filed: 1998-06-16
- Granted: 2004-04-27
- Earliest claimed: 1997-06-17
- Assignees: Human Genome Sciences, Inc.; Georgetown University Medical Center
- Inventors: Paul E. Young; C. Richter King; Mai Hijazi; Steven M. Ruben
- Web page: https://patentgrep.com/patent/US6727077B1

## CPC

- C07H 21/04: with deoxyribosyl as saccharide radical
- C07K 14/4756: {Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor}
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to a novel HLF protein which is a member of the heregulin family. In particular, isolated nucleic acid molecules are provided encoding the human HLF protein. HLF polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of HLF activity. Also provided are diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation of cell growth.

## Claims

### Claim 1

An isolated nucleic acid molecule comprising a polynucleotide sequence selected from the group consisting of:
(a) a polynucleotide encoding amino acid residues 1 to 157 of SEQ ID NO:2;
(b) a polynucleotide sequence encoding amino acid residues 1 to 101 of SEQ ID NO:2;
(c) a polynucleotide sequence encoding amino acid residues 26 to 93 of SEQ ID NO:2;
(d) a polynucleotide sequence encoding the full-length polypeptide having the amino acid sequence encoded by the cDNA clone contained in ATCC Deposit No. 209123;
(e) a polynucleotide sequence encoding the full-length polypeptide, minus the N-terminal methionine residue, having the amino acid sequence encoded by the cDNA clone contained in ATCC Deposit No. 209123; and
(f) a polynucleotide sequence fully complementary to any of the nucleic acid sequences in (a), (b), (c), (d), or (e) above.

### Claim 2 (depends on 1)

The isolated nucleic acid molecule of claim 1 which comprises polynucleotide sequence (a).

### Claim 3 (depends on 1)

The isolated nucleic acid molecule of claim 1 which comprises polynucleotide sequence (b).

### Claim 4 (depends on 1)

The isolated nucleic acid molecule of claim 1 which comprises polynucleotide sequence (c).

### Claim 5 (depends on 1)

The isolated nucleic acid molecule of claim 1 which comprises polynucleotide sequence (d).

### Claim 6 (depends on 1)

The isolated nucleic acid molecule of claim 1 which comprises polynucleotide sequence (e).

### Claim 7 (depends on 1)

The isolated nucleic acid molecule of claim 1 which comprises polynucleotide sequence (f).

### Claim 8 (depends on 1)

The isolated nucleic acid molecule of claim 1 wherein the polynucleotide sequence further comprises a heterologous polynucleotide sequence.

### Claim 9 (depends on 8)

The isolated nucleic acid molecule of claim 8 wherein the heterologous polynucleotide sequence encodes a heterologous polypeptide.

### Claim 10 (depends on 9)

The isolated nucleic acid molecule of claim 9 wherein the heterologous polypeptide is the Fc domain of immunoglobulin.

### Claim 11 (depends on 1)

A recombinant vector comprising the isolated nucleic acid molecule of claim 1.

### Claim 12 (depends on 11)

The recombinant vector of claim 11 wherein the nucleic acid molecule is operably associated with a heterologous regulatory sequence that controls gene expression.

### Claim 13 (depends on 1)

An isolated recombinant host cell comprising the isolated nucleic acid molecule of claim 1.

### Claim 14 (depends on 13)

The recombinant host cell of claim 13 wherein the nucleic acid molecule is operably associated with a heterologous regulatory sequence that controls gene expression.

### Claim 15 (depends on 1)

A method for producing a polypeptide, comprising:
(a) culturing a host cell under conditions suitable to produce a polypeptide encoded by the nucleic acid molecule of claim 1; and
(b) recovering the polypeptide from the cell culture.

### Claim 16 (depends on 1)

A composition comprising the polynucleotide of claim 1 and a carrier.

### Claim 17

An isolated nucleic acid molecule comprising a first polynucleotide sequence 90% or more identical to a second polynucleotide sequence from the group consisting of:
(a) a polynucleotide encoding amino acid residues 1 to 157 of SEQ ID NO: 2;
(b) a polynucleotide encoding amino acid residues 26 to 157 of SEQ ID NO:2; and
(c) a polynucleotide encoding amino acid residues 26 to 93 of SEQ ID NO:2;
wherein said nucleic acid molecule encodes a polypeptide with erbB receptor phosphorylation activity.

### Claim 18 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the first polynucleotide sequence is 90% or more identical to said second polynucleotide sequence (a).

### Claim 19 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the first polynucleotide sequence is 90% or more identical to said second polynucleotide sequence (b).

### Claim 20 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the first polynucleotide sequence is 90% or more identical to said second polynucleotide sequence (c).

### Claim 21 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the first polynucleotide sequence is 95% or more identical to said second polynucleotide sequence (a).

### Claim 22 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the first polynucleotide sequence is 95% or more identical to said second polynucleotide sequence (b).

### Claim 23 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the first polynucleotide sequence is 95% or more identical to said second polynucleotide sequence (c).

### Claim 24 (depends on 17)

The isolated nucleic acid molecule of claim 17 wherein the polynucleotide sequence further comprises a heterologous polynucleotide sequence.

### Claim 25 (depends on 24)

The isolated nucleic acid molecule of claim 24 wherein the heterologous polynucleotide sequence encodes a heterologous polypeptide.

### Claim 26 (depends on 25)

The isolated nucleic acid molecule of claim 25 wherein the heterologous polypeptide is the Fc domain of immunoglobulin.

### Claim 27 (depends on 17)

A recombinant vector comprising the isolated nucleic acid molecule of claim 17.

### Claim 28 (depends on 27)

The recombinant vector of claim 27 wherein the nucleic acid molecule is operably associated with a heterologous regulatory sequence that controls gene expression.

### Claim 29 (depends on 17)

An isolated recombinant host cell comprising the isolated nucleic acid molecule of claim 17.

### Claim 30 (depends on 29)

The recombinant host cell of claim 29 wherein the nucleic acid molecule is operably associated with a heterologous regulatory sequence that controls gene expression.

### Claim 31 (depends on 17)

A method for producing a polypeptide, comprising:
(a) culturing a host cell under conditions suitable to produce a polypeptide encoded by the nucleic acid molecule of claim 17; and
(b) recovering the polypeptide from the cell culture.

### Claim 32 (depends on 17)

A composition comprising the polynucleotide of claim 17 and a carrier.

### Claim 33

An isolated nucleic acid molecule consisting of 30 to 2199 contiguous nucleotides of SEQ ID NO:1.

### Claim 34 (depends on 33)

The isolated nucleic acid molecule of claim 33 which consists of 50 to 2199 contiguous nucleotides of SEQ ID NO:1.

### Claim 35 (depends on 33)

The isolated nucleic acid molecule of claim 33 wherein the polynucleotide sequence is fused to a heterologous polynucleotide sequence.

### Claim 36 (depends on 33)

A recombinant vector comprising the isolated nucleic acid molecule of claim 33.

### Claim 37 (depends on 33)

A recombinant host cell comprising the isolated nucleic acid molecule of claim 33.

### Claim 38 (depends on 33)

A composition comprising the polynucleotide of claim 33 and a carrier.
